To Cite:
Kchour
G, Fayyad-Kazan
M, Haddad
A, Badran
B, Tarhini
M. Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies,
Hepat Mon.
2017
; 17(2):e44787.
doi: 10.5812/hepatmon.44787.
1.
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[DOI][PubMed]
2.
European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57(1): 167-85[DOI][PubMed]
3.
Milich DR, Sallberg M, Maruyama T. The humoral immune response in acute and chronic hepatitis B virus infection. Springer Semin Immunopathol. 1995; 17(2-3): 149-66[DOI][PubMed]
4.
Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis. 2002; 2(1): 43-50[DOI][PubMed]
5.
Laperche S, Guitton C, Smilovici W, Courouce AM. Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen. Vox Sang. 2001; 80(2): 90-4[DOI][PubMed]
6.
Chan HL. Changing scene in hepatitis B serology interpretation. Hosp Med. 2002; 63(1): 16-9[DOI][PubMed]
7.
Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(15): 1927-38[DOI][PubMed]
8.
Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010; 4(10): 658-61[PubMed]
9.
Kang SY, Kim MH, Lee WI. The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea. J Med Virol. 2010; 82(9): 1508-14[DOI][PubMed]
10.
Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang. 1997; 73(2): 70-3[DOI][PubMed]
11.
Yotsuyanagi H,
Yasuda K,
Moriya K,
Shintani Y,
Fujie H,
Tsutsumi T,
et al.
Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2001; 41(9): 1093-9[DOI][PubMed]
12.
Huang CF, Lin SS, Ho YC, Chen FL, Yang CC. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol. 2006; 3(2): 97-106[PubMed]
13.
Galli C,
Orlandini E,
Penzo L,
Badiale R,
Caltran G,
Valverde S,
et al.
What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology? J Med Virol. 2008; 80(6): 974-9[DOI][PubMed]
14.
Kleinman SH,
Kuhns MC,
Todd DS,
Glynn SA,
McNamara A,
DiMarco A,
et al.
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003; 43(6): 696-704[DOI][PubMed]
15.
Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther. 2006; 10(2): 77-91[DOI][PubMed]
16.
Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol. 2001; 64(3): 312-9[DOI][PubMed]
17.
Manzini P,
Girotto M,
Borsotti R,
Giachino O,
Guaschino R,
Lanteri M,
et al.
Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica. 2007; 92(12): 1664-70[DOI][PubMed]
18.
Jutavijittum P,
Andernach IE,
Yousukh A,
Samountry B,
Samountry K,
Thammavong T,
et al.
Occult hepatitis B infections among blood donors in Lao PDR. Vox Sang. 2014; 106(1): 31-7[DOI][PubMed]
19.
Pisano MB, Blanco S, Carrizo H, Re VE, Gallego S. Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection. Arch Virol. 2016; 161(10): 2813-7[DOI][PubMed]
20.
Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Virol J. 2016; 13: 36[DOI][PubMed]
21.
Ramia S, Ramlawi F, Kanaan M, Klayme S, Naman R. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiol Infect. 2005; 133(4): 695-9[DOI][PubMed]
22.
Katz L, Strong DM, Tegtmeier G, Stramer S. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion. 2008; 48(11): 2315-22[DOI][PubMed]
23.
Altunay H,
Kosan E,
Birinci I,
Aksoy A,
Kirali K,
Saribas S,
et al.
Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination. Transfus Apher Sci. 2010; 43(3): 265-8[DOI][PubMed]
24.
Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med. 2004; 14(2): 97-103[DOI][PubMed]
25.
Lelie N,
Bruhn R,
Busch M,
Vermeulen M,
Tsoi WC,
Kleinman S,
et al.
Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing. Transfusion. 2017; 57(1): 24-35[DOI][PubMed]
26.
Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NG. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Transfusion. 2014; 54(8): 2084-91[DOI][PubMed]
27.
Enjalbert F, Krysztof DE, Candotti D, Allain JP, Stramer SL. Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors. Transfusion. 2014; 54(10): 2485-95[DOI][PubMed]
28.
Lin H,
Zhao H,
Tang X,
Hu W,
Jiang N,
Zhu S,
et al.
Serological patterns and molecular characterization of occult hepatitis b virus infection among blood donors. Hepat Mon. 2016; 16(10): 40492
Readers' Comments